Viridian Therapeutics, Inc. (VRDN)
14.88
-0.31
(-2.04%)
USD |
NASDAQ |
Apr 15, 16:00
14.88
0.00 (0.00%)
Pre-Market: 20:00
Viridian Therapeutics Shareholders Equity (Quarterly) : 722.17M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 16.80M |
| Amgen, Inc. | 8.658B |
| Boston Scientific Corp. | 24.23B |
| Plus Therapeutics, Inc. | 3.996M |
| Nutriband, Inc. | 7.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 899.42M |
| Total Liabilities (Quarterly) | 177.25M |
| Debt to Equity Ratio | 0.0702 |
| Current Ratio | 12.65 |
| Net Debt Paydown Yield | -0.17% |